Lung microRNA: From development to disease

Expert Review of Respiratory Medicine

Volumn 3, Issue 4, 2009, Pages 373-385

  Nana Sinkam, Serge Patrick ^a   Karsies, Todd ^b   Riscili, Brent ^a   Ezzie, Michael ^a   Piper, Melissa ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; COPD; Inflammation; Lung development; MiRNA

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA;

3' UNTRANSLATED REGION; CANCER INVASION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; IMMUNE RESPONSE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DEVELOPMENT; LUNG DISEASE; LUNG NON SMALL CELL CANCER; NONHUMAN; PATHOGENESIS; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70049116096     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.09.30     Document Type: Review

References (126)

1. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294(5543), 853-858 (2001).
2. Ambros V. The functions of animal microRNAs. Nature 431(7006), 350-355 (2004).
3. Murphy D, Dancis B, Brown JR. The evolution of core proteins involved in microRNA biogenesis. BMC. Evol. Biol. 8, 92 (2008).
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281-297 (2004).
5. Gregory RI, Yan KP, Amuthan G et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432(7014), 235-240 (2004).
6. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18(24), 3016-3027 (2004).
7. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10(2), 185-191 (2004).
8. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 303(5654),
9. -98 (2004). 9 Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20(14), 1885-1898 (2006).
10. Chu CY, Rana TM. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol. 4(7), e210 (2006).
11. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297(5589), 2056-2060 (2002).
12. Liu J, Rivas FV, Wohlschlegel J, Yates JR III, Parker R, Hannon GJ. A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 7(12), 1261-1266 (2005).
13. Meister G, Landthaler M, Peters L et al. Identification of novel argonaute-associated proteins. Curr. Biol. 15(23), 2149-2155 (2005).
14. Rehwinkel J, Behm-Ansmant I, Gatfield D, Izaurralde E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11(11), 1640-1647 (2005).
15. Wakiyama M, Takimoto K, Ohara O, Yokoyama S. Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev. 21(15), 1857-1862 (2007).
16. Wulczyn FG, Smirnova L, Rybak A et al. Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J. 21(2), 415-426 (2007).
17. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 115(7), 787-798 (2003).
18. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol. 3(3), e85 (2005).
19. Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev. 18(5), 504-511 (2004).
20. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27(1), 91-105 (2007).
21. Lai EC, Wiel C, Rubin GM. Complementary miRNA pairs suggest a regulatory role for miRNA:miRNA duplexes. RNA 10(2), 171-175 (2004).
22. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res. 69(8), 3245-3248 (2009).
23. Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc. Natl Acad. Sci. USA 104(23), 9667-9672 (2007).
24. Kim DH, Saetrom P, Snove O Jr, Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl Acad. Sci. USA 105(42), 16230-16235 (2008).
25. Orom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30(4), 460-471 (2008).
26. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA 14(5), 872-877 (2008).
27. Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl Acad. Sci. USA 105(39), 14879-14884 (2008).
28. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455(7216), 1124-1128 (2008).
29. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1), 15-20 (2005).
30. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol. 5(1), R1 (2003).
31. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol. 2(11), e363 (2004).
32. Wang X, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics. 24(3), 325-332 (2008).
33. Wu X, Piper-Hunter MG, Crawford M et al. MicroRNAs in the pathogenesis of lung cancer. J. Thorac. Oncol. (2009) (Epub ahead of print).
34. Nana-Sinkam SP, Hunter MG, Nuovo GJ et al. Integrating the MicroRNome into the study of lung disease. Am. J. Respir. Crit. Care Med. 179(1), 4-10 (2009).
35. Yang M, Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol. Ther. 117(1), 94-104 (2008).
36. Ambros V. microRNAs: tiny regulators with great potential. Cell 107(7), 823-826 (2001).
37. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle 6(17), 2127-2132 (2007).
38. Georgantas RW III, Hildreth R, Morisot S et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl Acad. Sci. USA 104(8), 2750-2755 (2007).
39. Hatfield S, Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res. 331(1), 57-66 (2008).
40. Matsubara H, Takeuchi T, Nishikawa E et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26(41), 6099-6105 (2007).
41. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014), 226-230 (2004).
42. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654), 83-86 (2004).
43. Kapsimali M, Kloosterman WP, de Bruijn E, Rosa F, Plasterk RH, Wilson SW. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 8(8), R173 (2007).
44. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8(2), 120-130 (2008).
45. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brainexpressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5(3), R13 (2004).
46. Thum T, Galuppo P, Wolf C et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116(3), 258-267 (2007).
47. Zhao Y, Ransom JF, Li A et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129(2), 303-317 (2007).
48. Lakshmipathy U, Love B, Goff LA et al. microRNA expression pattern of undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev. 16(6), 1003-1016 (2007).
49. Lu J, Guo S, Ebert BL et al. microRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev. Cell 14(6), 843-853 (2008).
50. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133(2), 217-222 (2008).
51. Harris KS, Zhang Z, McManus MT, Harfe BD, Sun X. Dicer function is essential for lung epithelium morphogenesis. Proc. Natl Acad. Sci. USA 103(7), 2208-2213 (2006).
52. Ventura A, Young AG, Winslow MM et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5), 875-886 (2008).
53. Wang Y, Weng T, Gou D, Chen Z, Chintagari NR, Liu L. Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics 8, 29 (2007).
54. Williams AE, Moschos SA, Perry MM, Barnes PJ, Lindsay MA. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev. Dyn. 236(2), 572-580 (2007).
55. Bernstein E, Kim SY, Carmell MA et al. Dicer is essential for mouse development. Nat. Genet. 35(3), 215-217 (2003).
56. Lu J, Qian J, Chen F, Tang X, Li C, Cardoso WV. Differential expression of components of the microRNA machinery during mouse organogenesis. Biochem. Biophys. Res. Commun. 334(2), 319-323 (2005).
57. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6(11), 857-866 (2006).
58. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 122(1), 6-7 (2005).
59. Kumar MS, Erkeland SJ, Pester RE et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl Acad. Sci. USA 105(10), 3903-3908 (2008).
60. Johnson SM, Grosshans H, Shingara J et al. RAS is regulated by the let-7 microRNA family. Cell 120(5), 635-647 (2005).
61. Mourelatos Z, Dostie J, Paushkin S et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16(6), 720-728 (2002).
62. Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J. Mol. Biol. 339(2), 327-335 (2004).
63. Landgraf P, Rusu M, Sheridan R et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7), 1401-1414 (2007).
64. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043), 839-843 (2005).
65. Lu Y, Okubo T, Rawlins E, Hogan BL. Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc. Am. Thorac. Soc. 5(3), 300-304 (2008).
66. Williams AE, Perry MM, Moschos SA, Lindsay MA. microRNA expression in the aging mouse lung. BMC Genomics 8, 172 (2007).
67. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310(2), 442-453 (2007).
68. Wikenheiser-Brokamp KA. Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development 131(17), 4299-4310 (2004).
69. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19(4), 348-355 (1998).
70. Freeman D, Lesche R, Kertesz N et al. Genetic background controls tumor development in PTEN-deficient mice. Cancer Res. 66(13), 6492-6496 (2006).
71. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl Acad. Sci. USA 102(31), 10898-10903 (2005).
72. Forstemann K, Horwich MD, Wee L, Tomari Y, Zamore PD. Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by Dicer-1. Cell 130(2), 287-297 (2007).
73. Baltimore D, Boldin MP, O'connell RM, Rao DS, Taganov KD. microRNAs: new regulators of immune cell development and function. Nat. Immunol. 9(8), 839-845 (2008).
74. Rodriguez A, Vigorito E, Clare S et al. Requirement of bic/ microRNA-155 for normal immune function. Science 316(5824), 608-611 (2007).
75. Johnnidis JB, Harris MH, Wheeler RT et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451(7182), 1125-1129 (2008).
76. Lindsay MA. microRNAs and the immune response. Trends Immunol. 29(7), 343-351 (2008).
77. Pedersen I, David M. MicroRNAs in the immune response. Cytokine 43(3), 391-394 (2008).
78. Tili E, Michaille JJ, Calin GA. Expression and function of micro-RNAs in immune cells during normal or disease state. Int. J. Med. Sci. 5(2), 73-79 (2008).
79. Thai TH, Calado DP, Casola S et al. Regulation of the germinal center response by microRNA-155. Science 316(5824), 604-608 (2007).
80. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104(5), 1604-1609 (2007).
81. Tili E, Michaille JJ, Cimino A et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179(8), 5082-5089 (2007).
82. Ceppi M, Pereira PM, Dunand-Sauthier I et al. microRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl Acad. Sci. USA 106(8), 2735-2740 (2009).
83. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103(33), 12481-12486 (2006).
84. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1b-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 180(8), 5689-5698 (2008).
85. Moschos SA, Williams AE, Perry MM, Birrell MA, Belvisi MG, Lindsay MA. Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 8, 240 (2007).
86. Zhai Y, Zhong Z, Chen CY et al. Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation. Mol. Cell Biol. 28(24), 7414-7426 (2008).
87. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23(3), 806-812 (2009).
88. Schembri F, Sridhar S, Perdomo C et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl Acad. Sci. USA 106(7), 2319-2324 (2009).
89. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 10. CA Cancer J. Clin. 57(1), 43-66 (2007).
90. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99(24), 15524-15529 (2002).
91. Takamizawa J, Konishi H, Yanagisawa K et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64(11), 3753-3756 (2004).
92. Johnson CD, Esquela-Kerscher A, Stefani G et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67(16), 7713-7722 (2007).
93. He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 435(7043), 828-833 (2005).
94. Dews M, Homayouni A, Yu D et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38(9), 1060-1065 (2006).
95. Hayashita Y, Osada H, Tatematsu Y et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65(21), 9628-9632 (2005).
96. Kim H, Kwon YM, Kim JS et al. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer 107(5), 1042-1049 (2006).
97. Fabbri M, Garzon R, Cimmino A et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104(40), 15805-15810 (2007).
98. Garofalo M, Quintavalle C, Di LG et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27(27), 3845-3855 (2008).
99. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 67(17), 7972-7976 (2007).
100. Nasser MW, Datta J, Nuovo G et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283(48), 33394-33405 (2008).
101. Chan JA, Krichevsky AM, Kosik KS. microRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65(14), 6029-6033 (2005).
102. Tavazoie SF, Alarcon C, Oskarsson T et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175), 147-152 (2008).
103. Crawford M, Brawner E, Batte K et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 373(4), 607-612 (2008).
104. Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration downregulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer (2009) (Epub ahead of print).
105. Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib 6. N. Engl. J. Med. 350(21), 2129-2139 (2004).
106. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem. 284(9), 5731-5741 (2009).
107. Weiss GJ, Bemis LT, Nakajima E et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol. 19(6), 1053-1059 (2008).
108. Mascaux C, Laes JF, Anthoine G et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur. Respir. J. 33(2), 352-359 (2009).
109. Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 29(12), 2394-2399 (2008).
110. Yanaihara N, Caplen N, Bowman E et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3), 189-198 (2006).
111. Yu SL, Chen HY, Chang GC et al. MicroRNA signature predicts survival and relapse in lung cancer 4. Cancer Cell 13(1), 48-57 (2008).
112. Bommer GT, Gerin I, Feng Y et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17(15), 1298-1307 (2007).
113. Liang Y. An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med. Genomics 1, 61 (2008).
114. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39(5), 673-677 (2007).
115. Karube Y, Tanaka H, Osada H et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96(2), 111-115 (2005).
116. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res. 67(20), 9609-9612 (2007).
117. Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12(4), 303-312 (2007).
118. Tan Z, Randall G, Fan J et al. Allelespecific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 81(4), 829-834 (2007).
119. Hu Z, Chen J, Tian T et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118(7), 2600-2608 (2008).
120. Chin LJ, Ratner E, Leng S et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res. 68(20), 8535-8540 (2008).
121. Hunter MP, Ismail N, Zhang X et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3(11), e3694 (2008).
122. Wang K, Zhang S, Marzolf B et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl Acad. Sci. USA 106(11), 4402-4407 (2009).
123. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10(1), 42-46 (2009).
124. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112(1), 55-59 (2009).
125. Gilad S, Meiri E, Yogev Y et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 3(9), e3148 (2008).
126. Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105(30), 10513-10518 (2008).